Skip to main content

Articles

Page 3 of 48

  1. Greater efforts are needed to overcome the worldwide reported low achievement of LDL-c targets. This survey aimed to dissect whether and how the physician-based evaluation of patients with diabetes is associat...

    Authors: Mario Luca Morieri, Olga Lamacchia, Enzo Manzato, Andrea Giaccari and Angelo Avogaro
    Citation: Cardiovascular Diabetology 2022 21:57

    The Correction to this article has been published in Cardiovascular Diabetology 2022 21:73

  2. Considering the nature of diabetes mellitus (DM) in coronary artery disease, it is unclear whether complete revascularization is beneficial or not in patients with DM. We investigated the clinical impact of an...

    Authors: Doyeon Hwang, Jiesuck Park, Han-Mo Yang, Seokhun Yang, Jeehoon Kang, Jung-Kyu Han, Kyung Woo Park, Hyun-Jae Kang, Bon-Kwon Koo and Hyo-Soo Kim
    Citation: Cardiovascular Diabetology 2022 21:56
  3. Insulin resistance is a risk factor for cardiovascular disease. Recently, we have developed a novel index, FLAIS (Fasting Laboratory Assessment of Insulin Sensitivity), which accurately reflects insulin sensit...

    Authors: Monika Karczewska-Kupczewska, Agnieszka Nikołajuk, Marcin Kondraciuk, Zofia Stachurska, Marlena Dubatówka, Anna Szpakowicz, Marek Strączkowski, Irina Kowalska and Karol Kamiński
    Citation: Cardiovascular Diabetology 2022 21:55
  4. Mildly elevated bilirubin, a by-product of hemoglobin breakdown, might mitigate cardiometabolic risk factors including adiposity, dyslipidemia, and high blood pressure (BP). We investigated the cross-sectional...

    Authors: Nazlisadat Seyed Khoei, Karl-Heinz Wagner, Anja M. Sedlmeier, Marc J. Gunter, Neil Murphy and Heinz Freisling
    Citation: Cardiovascular Diabetology 2022 21:54
  5. Although both type 2 diabetes mellitus (T2DM) and nonalcoholic fatty liver disease (NAFLD) are associated with increased risk of cardiovascular disease (CVD), evidence is lacking as to whether the presence of ...

    Authors: Jiyun Park, Gyuri Kim, Bong-Sung Kim, Kyung-Do Han, So Yoon Kwon, So Hee Park, You-Bin Lee, Sang-Man Jin and Jae Hyeon Kim
    Citation: Cardiovascular Diabetology 2022 21:53
  6. The prevention of subsequent cardiovascular disease (CVD) is an essential part of cancer survivorship care. We conducted the present study to investigate the association between the TyG index (a surrogate mark...

    Authors: Mi-Hyang Jung, Sang-Wook Yi, Sang Joon An, Jee-Jeon Yi, Sang-Hyun Ihm, Seongwoo Han, Kyu-Hyung Ryu, Hae Ok Jung and Ho-Joong Youn
    Citation: Cardiovascular Diabetology 2022 21:52
  7. Glucagon like peptide-1 receptor agonists (GLP-1RAs) have shown to reduce mortality and cardiovascular events in patients with type 2 diabetes mellitus (T2DM). Since the impairment in number and function of va...

    Authors: Annalisa Sforza, Vera Vigorelli, Erica Rurali, Gianluca Lorenzo Perrucci, Elisa Gambini, Martina Arici, Alessia Metallo, Raffaella Rinaldi, Paolo Fiorina, Andrea Barbuti, Angela Raucci, Elena Sacco, Marcella Rocchetti, Giulio Pompilio, Stefano Genovese and Maria Cristina Vinci
    Citation: Cardiovascular Diabetology 2022 21:51
  8. The 7th Cardiovascular Outcome Trial (CVOT) Summit on Cardiovascular, Renal, and Glycemic Outcomes, was held virtually on November 18–19, 2021. Pursuing the tradition of the previous summits, this reference co...

    Authors: Oliver Schnell, Tadej Battelino, Richard Bergenstal, Matthias Blüher, Michael Böhm, Frank Brosius, Richard D. Carr, Antonio Ceriello, Thomas Forst, Francesco Giorgino, Bruno Guerci, Hiddo J. L. Heerspink, Baruch Itzhak, Linong Ji, Mikhail Kosiborod, Nebojša Lalić…
    Citation: Cardiovascular Diabetology 2022 21:50
  9. Metformin has favorable effects on cardiovascular outcomes in both newly onset and advanced type 2 diabetes, as previously reported findings from the UK Prospective Diabetes Study and the HOME trial have demon...

    Authors: Johanna M. G. Stultiens, Wiebe M. C. Top, Dorien M. Kimenai, Philippe Lehert, Otto Bekers, Coen D. A. Stehouwer, Adriaan Kooy and Steven J. R. Meex
    Citation: Cardiovascular Diabetology 2022 21:49
  10. Stress hyperglycemia is a strong predictor of adverse outcomes in patients with acute myocardial infarction (AMI). Recently, the stress hyperglycemia ratio (SHR) has been designed as an index to identify acute...

    Authors: Wei Xu, Yan-min Yang, Jun Zhu, Shuang Wu, Juan Wang, Han Zhang and Xing-hui Shao
    Citation: Cardiovascular Diabetology 2022 21:48
  11. We conducted a systematic review and meta-analysis of the cardiovascular, kidney, and safety outcomes of sodium-glucose cotransporter 2 inhibitors (SGLT2i) among patients with diabetic kidney disease (DKD).

    Authors: Arnaud D. Kaze, Min Zhuo, Seoyoung C. Kim, Elisabetta Patorno and Julie M. Paik
    Citation: Cardiovascular Diabetology 2022 21:47
  12. Inflammation plays a crucial role in coronary atherosclerosis progression, and growing evidence has demonstrated that the fibrinogen-to-albumin ratio (FAR), as a novel inflammation biomarker, is associated wit...

    Authors: Peizhi Wang, Deshan Yuan, Ce Zhang, Pei Zhu, Sida Jia, Ying Song, Xiaofang Tang, Jingjing Xu, Tianyu Li, Guyu Zeng, Xueyan Zhao, Yuejin Yang, Bo Xu, Runlin Gao and Jinqing Yuan
    Citation: Cardiovascular Diabetology 2022 21:46
  13. Sodium-glucose-cotransporter 2 inhibitors (SGLT2is) demonstrate large cardiovascular benefit in both diabetic and non-diabetic, acute and chronic heart failure patients. These inhibitors have on-target (SGLT2 ...

    Authors: Sha Chen, Ruben Coronel, Markus W. Hollmann, Nina C. Weber and Coert J. Zuurbier
    Citation: Cardiovascular Diabetology 2022 21:45
  14. Pericoronary adipose tissue (PCAT) attenuation on coronary computed tomography angiography (CTA) is a non-invasive biomarker for pericoronary inflammation. We aimed to investigate the prognostic value of PCAT ...

    Authors: Keishi Ichikawa, Toru Miyoshi, Kazuhiro Osawa, Mitsutaka Nakashima, Takashi Miki, Takahiro Nishihara, Hironobu Toda, Masatoki Yoshida and Hiroshi Ito
    Citation: Cardiovascular Diabetology 2022 21:44
  15. Triglyceride glucose (TyG) index was recently reported to be associated with an increased risk of the development and recurrence of cardiovascular events, and atherosclerosis is a main speculative mechanism. H...

    Authors: Mengyuan Miao, Guo Zhou, Anran Bao, Yaming Sun, Huaping Du, Liyan Song, Yongjun Cao, Shoujiang You and Chongke Zhong
    Citation: Cardiovascular Diabetology 2022 21:43
  16. Glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium glucose co-transporter-2 (SGLT-2) inhibitors reduce cardiorenal outcomes. We performed a network meta-analysis to compare the effect on cardiorena...

    Authors: Dario Giugliano, Miriam Longo, Simona Signoriello, Maria Ida Maiorino, Bruno Solerte, Paolo Chiodini and Katherine Esposito
    Citation: Cardiovascular Diabetology 2022 21:42
  17. New onset diabetes after transplantation (NODAT) is a frequent and serious complication of renal transplantation resulting in worse graft and patient outcomes. The pathophysiology of NODAT is incompletely unde...

    Authors: Tamas Szili-Torok, Sara Sokooti, Maryse C. J. Osté, Antonio W. Gomes-Neto, Robin P. F. Dullaart, Stephan J. L. Bakker and Uwe J. F. Tietge
    Citation: Cardiovascular Diabetology 2022 21:41
  18. Distinguishable sex differences exist in fat mass and muscle mass. High fat mass and low muscle mass are independently associated with cardiovascular disease (CVD) risk factors in people living with type 2 dia...

    Authors: Tasuku Terada, Jennifer L. Reed, Sol Vidal-Almela, Matheus Mistura, Kentaro Kamiya and Kimberley L. Way
    Citation: Cardiovascular Diabetology 2022 21:40
  19. Atrial fibrillation (AF) and diabetes mellitus (DM) constitute two major closely inter-related chronic cardiovascular disorders whose concurrent prevalence rates are steadily increasing. Although, the pathogen...

    Authors: Andreas S. Papazoglou, Anastasios Kartas, Dimitrios V. Moysidis, Christos Tsagkaris, Stavros P. Papadakos, Alexandra Bekiaridou, Athanasios Samaras, Efstratios Karagiannidis, Marios Papadakis and George Giannakoulas
    Citation: Cardiovascular Diabetology 2022 21:39
  20. The triglyceride glucose (TyG) index serves as a surrogate indicator of insulin resistance. However, there is limited evidence on the association between the TyG index and carotid artery plaque (CAP) in patien...

    Authors: Zhu Li, Yuanyuan He, Shuo Wang, Lin Li, Rongrong Yang, Yijia Liu, Qi Cheng, Lu Yu, Yanchao Zheng, Hongmei Zheng, Shan Gao and Chunquan Yu
    Citation: Cardiovascular Diabetology 2022 21:38
  21. Type 2 diabetes mellitus causes left ventricular (LV) remodeling and increases the risk of aortic regurgitation (AR), which causes further heart damage. This study aimed to investigate whether AR aggravates LV...

    Authors: Li-Ting Shen, Li Jiang, Ya-Wen Zhu, Meng-Ting Shen, Shan Huang, Rui Shi, Yuan Li and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2022 21:37
  22. Soluble suppression of tumorigenesis-2 (sST2) and galectin (Gal)-3 are two biomarkers related to inflammation, metabolic disturbances and to myocardial fibrosis that characterize several cardiac pathological c...

    Authors: Paola Simeone, Romina Tripaldi, Annika Michelsen, Thor Ueland, Rossella Liani, Sonia Ciotti, Kåre I. Birkeland, Hanne L. Gulseth, Augusto Di Castelnuovo, Francesco Cipollone, Pål Aukrust, Agostino Consoli, Bente Halvorsen and Francesca Santilli
    Citation: Cardiovascular Diabetology 2022 21:36
  23. The prevalence of prediabetes is increasing in the global population and its metabolic derangements may expose to a higher risk to develop type 2 diabetes (T2D) and its cardiovascular burden. Lifestyle modific...

    Authors: Lucia La Sala, Elena Tagliabue, Simona Mrakic-Sposta, Anna Chiara Uccellatore, Pamela Senesi, Ileana Terruzzi, Emilio Trabucchi, Luigi Rossi-Bernardi and Livio Luzi
    Citation: Cardiovascular Diabetology 2022 21:35
  24. Plasma growth differentiation factor-15 (GDF-15) biomarker levels increase in response to inflammation and tissue injury, and increased levels of GDF-15 are associated with increased risk of mortality in patie...

    Authors: Massar Omar, Jesper Jensen, Caroline Kistorp, Kurt Højlund, Lars Videbæk, Christian Tuxen, Julie H. Larsen, Camilla F. Andersen, Finn Gustafsson, Lars Køber, Morten Schou and Jacob Eifer Møller
    Citation: Cardiovascular Diabetology 2022 21:34
  25. The triglyceride-glucose index (TyG index) has emerged as a reliable surrogate marker of insulin resistance associated with arterial stiffness. However, most studies were based on a cross-sectional design, and...

    Authors: Yu Yan, Dan Wang, Yue Sun, Qiong Ma, Keke Wang, Yueyuan Liao, Chen Chen, Hao Jia, Chao Chu, Wenling Zheng, Jiawen Hu, Yue Yuan, Yang Wang, Yuliang Wu and Jianjun Mu
    Citation: Cardiovascular Diabetology 2022 21:33
  26. The association between visceral adiposity index (VAI) and diabetic complications has been reported in cross-sectional studies, while the effect of VAI on complication development remains unclear. This study a...

    Authors: Zhiyuan Wu, Siqi Yu, Xiaoping Kang, Yue Liu, Zongkai Xu, Zhiwei Li, Jinqi Wang, Xinlei Miao, Xiangtong Liu, Xia Li, Jingbo Zhang, Wei Wang, Lixin Tao and Xiuhua Guo
    Citation: Cardiovascular Diabetology 2022 21:32
  27. Type 2 diabetes (T2D) is associated with coronary microvascular dysfunction, which is thought to contribute to compromised diastolic function, ultimately culminating in heart failure with preserved ejection fr...

    Authors: Shawn Veitch, Makon-Sébastien Njock, Mark Chandy, M. Ahsan Siraj, Lijun Chi, HaoQi Mak, Kai Yu, Kumaragurubaran Rathnakumar, Carmina Anjelica Perez-Romero, Zhiqi Chen, Faisal J. Alibhai, Dakota Gustafson, Sneha Raju, Ruilin Wu, Dorrin Zarrin Khat, Yaxu Wang…
    Citation: Cardiovascular Diabetology 2022 21:31
  28. Coronary artery disease (CAD) confers considerable morbidity and mortality in diabetes. However, the role of CAD in additive effect of left ventricular (LV) function has rarely been explored in type 2 diabetes...

    Authors: Jin Wang, Yuan Li, Ying-Kun Guo, Shan Huang, Rui Shi, Wei-Feng Yan, Wen-Lei Qian, Guang-Xi He and Zhi-Gang Yang
    Citation: Cardiovascular Diabetology 2022 21:30
  29. Non-diabetic coronary artery disease (CAD) patients are thought to encounter metabolic dysfunction and while these changes may be imperceptible to the patient they probably influence outcomes. At present, ther...

    Authors: Yitian Zheng, Chen Li, Jie Yang, Samuel Seery, Yu Qi, Wenyao Wang, Kuo Zhang, Chunli Shao and Yi-Da Tang
    Citation: Cardiovascular Diabetology 2022 21:29
  30. Current guidelines recommend life-long use of statin for patients with type 2 diabetes (T2D), however, a number of patients discontinue statin therapy in clinical practice. We aimed to estimate the optimal sta...

    Authors: Ji Yoon Kim, Jimi Choi, Sin Gon Kim and Nam Hoon Kim
    Citation: Cardiovascular Diabetology 2022 21:28
  31. Empagliflozin can curb inflammation and oxidative stress, through sodium-proton exchanger (NHE) inhibition, in a model of lipotoxicity in human myeloid angiogenic cells (MAC), which mediate endothelial repairi...

    Authors: Gloria Cinquegrani, Valentina Spigoni, Federica Fantuzzi, Riccardo C. Bonadonna and Alessandra Dei Cas
    Citation: Cardiovascular Diabetology 2022 21:27
  32. Iron stores, estimated as ferritin levels, and type 2 diabetes (T2D) have been associated previously, while findings regarding coronary heart disease (CHD) and cerebrovascular disease (CEVD) are still inconclu...

    Authors: Milton-Fabian Suárez-Ortegón, Stela McLachlan, José-Manuel Fernandez-Real, Tomi-Pekka Tuomainen, Alex Aregbesola and Sarah H. Wild
    Citation: Cardiovascular Diabetology 2022 21:26
  33. Altered adipokine secretion in dysfunctional adipose tissue facilitates the development of atherosclerotic diseases including lower extremity peripheral artery disease (PAD). Asprosin is a recently identified ...

    Authors: Mei You, Yushuang Liu, Bowen Wang, Li Li, Hexuan Zhang, Hongbo He, Qing Zhou, Tingbing Cao, Lijuan Wang, Zhigang Zhao, Zhiming Zhu, Peng Gao and Zhencheng Yan
    Citation: Cardiovascular Diabetology 2022 21:25
  34. Pre-existing cardiometabolic comorbidities place SARS-CoV-2 positive patients at a greater risk for poorer clinical course and mortality than those without it. We aimed to analyze real-world registry data focu...

    Authors: Parth Shah, Kim Magee, Kiara H. Buccellato, McKenna Ismond and Jalisa Watson
    Citation: Cardiovascular Diabetology 2022 21:24
  35. Restenosis, defined as the re-narrowing of an arterial lumen after revascularization, represents an increasingly important issue in clinical practice. Indeed, as the number of stent placements has risen to an ...

    Authors: Scott Wilson, Pasquale Mone, Urna Kansakar, Stanislovas S. Jankauskas, Kwame Donkor, Ayobami Adebayo, Fahimeh Varzideh, Michael Eacobacci, Jessica Gambardella, Angela Lombardi and Gaetano Santulli
    Citation: Cardiovascular Diabetology 2022 21:23
  36. The identification of circulating biomarkers associated with the risk of type 2 diabetes (T2D) is useful for improving the current prevention strategies in the most at-risk patients. Here, we aimed to investig...

    Authors: Mikaël Croyal, Matthieu Wargny, Kevin Chemello, Chloé Chevalier, Valentin Blanchard, Edith Bigot-Corbel, Gilles Lambert, Cédric Le May, Samy Hadjadj and Bertrand Cariou
    Citation: Cardiovascular Diabetology 2022 21:21
  37. There is uncertainty and limited data regarding initiation of sodium-glucose cotransporter 2 (SGLT2) inhibitors among patients hospitalized with acute heart failure (AHF). This systematic review and meta-analy...

    Authors: Husam M. Salah, Subhi J. Al’Aref, Muhammad Shahzeb Khan, Malek Al-Hawwas, Srikanth Vallurupalli, Jawahar L. Mehta, J. Paul Mounsey, Stephen J. Greene, Darren K. McGuire, Renato D. Lopes and Marat Fudim
    Citation: Cardiovascular Diabetology 2022 21:20
  38. Since sodium-glucose cotransporter 2 (SGLT2) inhibitors have a pleiotropic antiatherogenic effect, they are expected to attenuate the progression of atherosclerosis. However, whether SGLT2 inhibitors affect th...

    Authors: Naoto Katakami, Tomoya Mita, Norikazu Maeda, Yasunori Sato, Hirotaka Watada and Iichiro Shimomura
    Citation: Cardiovascular Diabetology 2022 21:19
  39. The gut incretin hormones GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide) are secreted by enteroendocrine cells following food intake leading to insulin secretion and glucose...

    Authors: Florian Kahles, Matthias Rau, Martin Reugels, Ann C. Foldenauer, Robert W. Mertens, Maria C. Arrivas, Jörg Schröder, Paul Idel, Julia Moellmann, Emiel P. C. van der Vorst, Nikolaus Marx and Michael Lehrke
    Citation: Cardiovascular Diabetology 2022 21:18
  40. Elevated endothelial microparticles (EMPs) levels are surrogate markers of vascular dysfunction. We analyzed EMPs with apoptotic characteristics and assessed the angiogenic contents of microparticles in the bl...

    Authors: Isra Marei, Omar Chidiac, Binitha Thomas, Jennifer Pasquier, Soha Dargham, Amal Robay, Muneera Vakayil, Mohammad Jameesh, Christopher Triggle, Arash Rafii, Amin Jayyousi, Jassim Al Suwaidi and Charbel Abi Khalil
    Citation: Cardiovascular Diabetology 2022 21:17
  41. It remains unclear how the variability of adiposity indices relates to incident HF. This study evaluated the associations of the variability in several adiposity indices with incident heart failure (HF) in ind...

    Authors: Arnaud D. Kaze, Sebhat Erqou, Prasanna Santhanam, Alain G. Bertoni, Rexford S. Ahima, Gregg C. Fonarow and Justin B. Echouffo-Tcheugui
    Citation: Cardiovascular Diabetology 2022 21:16
  42. Diabetes have been known as a traditional risk factor of developing peripheral artery disease (PAD). However, the study evaluating the impact of long-term glycemic variability on the risk of developing PAD is ...

    Authors: Hye Soo Chung, Soon Young Hwang, Jung A. Kim, Eun Roh, Hye Jin Yoo, Sei Hyun Baik, Nan Hee Kim, Ji A. Seo, Sin Gon Kim, Nam Hoon Kim and Kyung Mook Choi
    Citation: Cardiovascular Diabetology 2022 21:15
  43. Whether smoking modifies the associations of diabetes and risk factor management with subsequent risk of cardiovascular disease (CVD), and whether the smoking related CVD risk differs among people with and wit...

    Authors: Yang Yang, Nianchun Peng, Gang Chen, Qin Wan, Li Yan, Guixia Wang, Yingfen Qin, Zuojie Luo, Xulei Tang, Yanan Huo, Ruying Hu, Zhen Ye, Guijun Qin, Zhengnan Gao, Qing Su, Yiming Mu…
    Citation: Cardiovascular Diabetology 2022 21:14
  44. HbA1c variability has emerged as risk factor for cardiovascular diseases in diabetes. However, the impact of HbA1c variability on cardiovascular diseases in subjects within the recommended HbA1c target has bee...

    Authors: Antonio Ceriello, Giuseppe Lucisano, Francesco Prattichizzo, Rosalba La Grotta, Stefan Franzén, Ann-Marie Svensson, Björn Eliasson and Antonio Nicolucci
    Citation: Cardiovascular Diabetology 2022 21:13
  45. Guidelines recommend physical activity to reduce cardiovascular (CV) events. The association between physical activity and progression of chronic kidney disease (CKD) with and without diabetes is unknown. We a...

    Authors: Michael Böhm, Helmut Schumacher, Christian Werner, Koon K. Teo, Eva M. Lonn, Felix Mahfoud, Thimoteus Speer, Giuseppe Mancia, Josep Redon, Roland E. Schmieder, Karen Sliwa, Nikolaus Marx, Michael A. Weber, Ulrich Laufs, Bryan Williams, Salim Yusuf…
    Citation: Cardiovascular Diabetology 2022 21:12
  46. It has been demonstrated that glycated albumin (GA) is significantly associated with diabetes complications and mortality. However, among patients diagnosed with non-ST-elevation acute coronary syndrome (NSTE-...

    Authors: Chi Liu, Qi Zhao, Xiaoteng Ma, Yujing Cheng, Yan Sun, Dai Zhang, Xiaoli Liu and Yujie Zhou
    Citation: Cardiovascular Diabetology 2022 21:11
  47. Diabetes and hypertension are common in older adults and represent established risk factors for frailty. Frailty is a multidimensional condition due to reserve loss and susceptibility to stressors with a high ...

    Authors: Pasquale Mone, Jessica Gambardella, Angela Lombardi, Antonella Pansini, Stefano De Gennaro, Anna Luisa Leo, Michele Famiglietti, Anna Marro, Maria Morgante, Salvatore Frullone, Antonio De Luca and Gaetano Santulli
    Citation: Cardiovascular Diabetology 2022 21:10
  48. Coronary artery ectasia (CAE) is a rare finding in coronary angiography and associated with poor clinical outcomes. Unlike atherosclerosis, diabetes mellitus (DM) is not commonly associated with CAE. This stud...

    Authors: Zhongxing Cai, Luqi Li, Haoyu Wang, Sheng Yuan, Dong Yin, Weihua Song and Kefei Dou
    Citation: Cardiovascular Diabetology 2022 21:9
  49. To assess trends in primary and specialist care consultation rates and average length of consultation by cardiovascular disease (CVD), type 2 diabetes mellitus (T2DM), or cardiometabolic multimorbidity exposur...

    Authors: Sophia Abner, Clare L. Gillies, Sharmin Shabnam, Francesco Zaccardi, Samuel Seidu, Melanie J. Davies, Tobi Adeyemi, Kamlesh Khunti and David R. Webb
    Citation: Cardiovascular Diabetology 2022 21:8

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Annual Journal Metrics